Vitamin D Replacement Dosing for Deficiency
For a 25-year-old male with a vitamin D level of 15 ng/mL, prescribe 50,000 IU of vitamin D3 (cholecalciferol) once weekly for 8 weeks, followed by maintenance therapy of 1,500-2,000 IU daily. 1
Treatment Rationale
This patient has clear vitamin D deficiency (level <20 ng/mL) requiring aggressive repletion. The Endocrine Society Clinical Practice Guideline provides the most authoritative framework for management 1.
Repletion Phase (Weeks 1-8)
The standard approach uses 50,000 IU weekly for 8 weeks (total cumulative dose of 400,000 IU). This regimen is specifically designed to raise 25(OH)D levels from deficient ranges (<20 ng/mL) to above 30 ng/mL 1.
Alternative equivalent dosing: 6,000 IU daily for 8 weeks can be used if weekly dosing is not feasible, though weekly dosing improves compliance 1.
Research supports this approach shows that cumulative doses of 200,000 IU increase mean serum 25(OH)D by approximately 69 nmol/L (27.6 ng/mL), which would bring this patient from 15 ng/mL to approximately 42-43 ng/mL 2.
Maintenance Phase (After Week 8)
Following repletion, maintenance therapy of 1,500-2,000 IU daily prevents recurrence of deficiency 1. Some evidence suggests higher maintenance doses (2,000-4,000 IU daily) may be needed to maintain optimal levels above 30 ng/mL, particularly in individuals with limited sun exposure 3, 4.
Special Considerations for This Patient
Body Weight Matters
If this patient is obese (BMI ≥30), he requires 2-3 times higher doses (at least 6,000-10,000 IU daily during repletion, followed by 3,000-6,000 IU daily for maintenance) 1. The dose-response relationship is significantly affected by body weight, with the equation: Δ25(OH)D = 0.025 × (dose per kg body weight) 2.
Monitoring Protocol
- Recheck 25(OH)D level at 8-12 weeks after starting therapy
- Target level: >30 ng/mL for optimal bone health and extra-skeletal benefits 1
- If levels fail to rise appropriately, consider malabsorption (celiac disease, cystic fibrosis) assuming compliance 1
Common Pitfalls to Avoid
Don't underdose: The recommended daily allowance (400-600 IU) is grossly inadequate for correcting deficiency. Studies show approximately 5,000 IU daily is typically needed for correction 3.
Don't use vitamin D2 (ergocalciferol) preferentially: While the guideline mentions both D2 and D3 as equivalent, vitamin D3 (cholecalciferol) has superior pharmacokinetic properties and is the preferred formulation 5, 6.
Don't skip maintenance: 50,000 IU every other week can be used as an alternative maintenance strategy if daily dosing is problematic 1.
Safety Considerations
This dosing regimen is safe. Hypercalcemia and toxicity are rare at these doses and typically only occur when 25(OH)D levels exceed 150 ng/mL 1. No hypercalcemia or hypercalciuria was observed in studies using similar or higher doses 4. Calcium monitoring is not routinely necessary in healthy young adults without comorbidities.